Human Genome (HGSI) Shares Moving as Reuters Says Glaxo (GSK) Wants to Replace Entire Board
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Join SI Premium – FREE
Traders watch Human Genome Sciences (Nasdaq: HGSI) shares as the stock is moving following a Reuters report GlaxoSmithKline (NYSE: GSK) will likely begin a campaign to replace the entire Human Genome Board.
Human Genome shares last traded at $13.92, up about 0.7 percent from Tuesday's close. The stock traded as low as $13.55 earlier.
Human Genome shares last traded at $13.92, up about 0.7 percent from Tuesday's close. The stock traded as low as $13.55 earlier.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
Create E-mail Alert Related Categories
Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
